Toronto Metropolitan University is a public research university located in Toronto, Ontario, Canada. The university's core campus is situated within the Garden District, although it also operates facilities elsewhere in Toronto.

During the past decade, Ryerson University conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ryerson University" #1 sponsor was "Ryerson University" with 19 trials, followed by "Baylor College of Medicine" with 1 trials sponsored, "Centre hospitalier de l'Université de Montréal (CHUM)" with 1 trials sponsored, "Kirstyn L. Krause" with 1 trials sponsored and "York University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ryerson University" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator, "Ministry of Research, Innovation and Science, Ontario" with 3 trials as a collaborator, "Mitacs" with 2 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator and "BMS Canada Risk Services Ltd." with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Ryerson University" are "Excessive Worry" (3 trials), "HIV" (3 trials), "Anger" (2 trials), "Generalized Anxiety Disorder" (2 trials) and "Insomnia" (2 trials). Many other conditions were trialed in "Ryerson University" in a lesser frequency.

Most popular intervention types in "Ryerson University" are "Behavioral" (19 trials), "Drug" (2 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control Condition" (2 trials), "Adapted Motivational Interviewing (AMI) and Cognitive Behavioural Therapy (CBT)" (1 trials), "Applied Relaxation" (1 trials), "Attention Training Technique" (1 trials) and "Auditory Beat Stimulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ryerson University" are 15 trials for "All" genders, 6 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ryerson University". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Ryerson University, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ryerson University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 19 trials that are defined as “Not Applicable".